日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer

磁共振成像预测HER2阴性乳腺癌新辅助化疗（联合或不联合贝伐珠单抗治疗）的疗效和10年预后

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030393
Brandal, Siri Helene Bertelsen; Mo, Torgeir; Fangberget, Anne; Nilsen, Line Brennhaug; Geier, Oliver Marcel; Bjørndal, Hilde; Holmen, Marit Muri; Engebråten, Olav; Garred, Øystein; Hole, Knut Håkon; Seierstad, Therese
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis

携带DICER1突变的原发性子宫外胚间质瘤：病例报告及分子分析

期刊:Virchows Archiv
影响因子:3.1
doi:10.1007/s00428-021-03057-x
Davidson, Ben; Kleinberg, Lilach; Børresen, Ida Marie; Slettevoll, Frøydis; Fangberget, Anne; Hindosh, Dunia; Zahl Eriksson, Ane Gerda; Bjerkehagen, Bodil
DICER
发表日期：2021
文献求助 收藏

Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations

利用不同b值组合对恶性乳腺病变的扩散加权磁共振成像进行定量分析

期刊:European Radiology
影响因子:4.7
doi:10.1007/s00330-012-2687-8
Nilsen, Line B; Fangberget, Anne; Geier, Oliver; Seierstad, Therese
发表日期：2013
文献求助 收藏

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

乳腺癌新辅助化疗——利用动态增强和弥散加权磁共振成像评估和预测治疗反应

期刊:European Radiology
影响因子:4.7
doi:10.1007/s00330-010-2020-3
Fangberget, A; Nilsen, L B; Hole, K H; Holmen, M M; Engebraaten, O; Naume, B; Smith, H-J; Olsen, D R; Seierstad, T
肿瘤
肿瘤免疫
乳腺癌
发表日期：2011
文献求助 收藏